Reirradiation in squamous cell head and neck cancer: recent developments and future directions.

Détails

ID Serval
serval:BIB_E1985ABB270C
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
Périodique
Current Opinion in Oncology
Auteur⸱e⸱s
Langendijk J.A., Bourhis J.
ISSN
1040-8746 (Print)
ISSN-L
1040-8746
Statut éditorial
Publié
Date de publication
2007
Peer-reviewed
Oui
Volume
19
Numéro
3
Pages
202-209
Langue
anglais
Notes
Publication types: Journal Article ; Review Publication Status: ppublish
Résumé
PURPOSE OF REVIEW: The purpose of this review is to highlight the most important developments in the management of recurrent or second primary head and neck carcinoma in previously irradiated areas by reirradiation that have been published in the medical literature in the past year.
RECENT FINDINGS: Recent research indicates that long-term survival can be achieved in a proportion of patients using more advanced chemo-reirradiation protocols in the primary as well as in postoperative reirradiation setting. Despite the promising results with regard to locoregional tumour control and survival, treatment-related acute and late morbidity remains of major concern.
SUMMARY: As an increasing number of patients currently receive more effective initial treatment regimens, recurrent and second primary tumours in previously irradiated areas nowadays may represent a more radio-resistant population than reported in previous studies. Therefore, full-dose chemo-reirradiation should only be applied in well selected cases.
Mots-clé
Carcinoma, Squamous Cell/drug therapy, Carcinoma, Squamous Cell/mortality, Combined Modality Therapy/trends, Dose Fractionation, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/mortality, Humans, Neoplasm Recurrence, Local/drug therapy, Neoplasm Recurrence, Local/radiotherapy, Neoplasms, Second Primary/drug therapy, Neoplasms, Second Primary/radiotherapy, Salvage Therapy, Survival Rate, Treatment Outcome
Pubmed
Web of science
Création de la notice
01/12/2014 18:30
Dernière modification de la notice
20/08/2019 17:05
Données d'usage